Différences
Ci-dessous, les différences entre deux révisions de la page.
| Les deux révisions précédentes Révision précédente Prochaine révision | Révision précédente | ||
|
acupuncture:evaluation:neuro-psychiatrie:14. maladie d alzheimer [18 Dec 2020 09:21] Nguyen Johan [2.1. National Institute for Health and Care Excellence (NICE, UK) 2018] |
acupuncture:evaluation:neuro-psychiatrie:14. maladie d alzheimer [15 Jun 2025 07:04] (Version actuelle) Nguyen Johan [1.1.1. Wu 2025] |
||
|---|---|---|---|
| Ligne 4: | Ligne 4: | ||
| - | ====== Maladie d'Alzheimer : évaluation de l'acupuncture ====== | + | ====== Maladie d'Alzheimer ====== |
| | //Articles connexes//: - [[acupuncture:acupuncture experimentale:pathologies experimentales:pathologies neuro-psychiatriques et systeme nerveux#Maladie d'Alzheimer|acupuncture expérimentale]] - | | | //Articles connexes//: - [[acupuncture:acupuncture experimentale:pathologies experimentales:pathologies neuro-psychiatriques et systeme nerveux#Maladie d'Alzheimer|acupuncture expérimentale]] - | | ||
| ===== Systematic Reviews and Meta-Analysis===== | ===== Systematic Reviews and Meta-Analysis===== | ||
| - | | ☆☆☆ | Evidence for effectiveness and a specific effect of acupuncture | | + | |
| - | | ☆☆ | Evidence for effectiveness of acupuncture | | + | |
| - | | ☆ |Limited evidence for effectiveness of acupuncture | | + | |
| - | | Ø |No evidence or insufficient evidence | | + | |
| ==== Generic Acupuncture ==== | ==== Generic Acupuncture ==== | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | === Wu J 2025 === | ||
| + | |||
| + | Wu J, Teng Y, Xie Y, Xing S, Zhi S. Comparing the efficacy of physical therapy interventions in Alzheimer's disease: a network meta-analysis. Front Aging Neurosci. 2025 Mar 5;17:1541287. https://doi.org/10.3389/fnagi.2025.1541287 | ||
| + | ^Backgroung| Alzheimer's disease (AD) is a progressive and debilitating neurodegenerative disorder that significantly impairs cognitive function and daily living abilities, representing a major public health challenge. Given the multifactorial nature of AD, effective therapeutic interventions targeting both cognitive and functional decline are critical. | | ||
| + | ^Methods|This study aimed to conduct a comprehensive comparison of the therapeutic effects of music therapy, acupuncture therapy, game therapy, cognitive training therapy, and exercise therapy on AD patients through a network meta-analysis. Randomized controlled trials (RCTs) published up until 2024 were systematically retrieved from multiple databases. Data were extracted, including the first author, publication year, country, total sample size, mean participant age, type and duration of intervention, and outcome measures such as the Mini-Mental State Examination, Activities of Daily Living, and Alzheimer's Disease Assessment Scale-Cognitive Subscale. Statistical analyses were performed using the RevMan 5.3 and Stata 17 software. The analysis included 52 RCTs with a total of 3,409 participants, offering a strong dataset. | | ||
| + | ^Results| The results indicated that game therapy produced statistically significant improvements in mental state and daily living abilities, while acupuncture therapy yielded the most pronounced improvements in cognitive function among AD patients. Notably, the comparative efficacy of these interventions suggests that game therapy may offer short-term benefits, particularly for mental health and functional abilities, whereas **acupuncture therapy** demonstrated superior long-term cognitive enhancements. | | ||
| + | ^Conclusions| In conclusion, tailored physical and cognitive interventions such as game therapy and **acupuncture therapy** may hold significant potential in optimizing treatment outcomes for AD patients, with implications for both clinical practice and future research.| | ||
| + | |||
| + | |||
| + | === Wu Y 2025 (combined with donepezil) === | ||
| + | |||
| + | |||
| + | Wu Y, Zhan Y, Zhu W, Pei J. Effectiveness of acupuncture combined with donepezil for Alzheimer's disease: A systematic review and meta-analysis. Medicine (Baltimore). 2025 Jun 6;104(23):e42651. https://doi.org/10.1097/MD.0000000000042651 | ||
| + | ^Backgound| The incidence of Alzheimer's disease (AD) is gradually increasing in an aging society, imposing a heavy burden on society. Current studies have found that acupuncture therapy combined with donepezil has a good clinical effect in treating AD. We plan to conduct a systematic review and meta-analysis to evaluate the effectiveness of acupuncture combined with donepezil in AD patients.| | ||
| + | ^Methods| Eight databases were searched for randomized controlled trials (RCTs) using acupuncture in combination with donepezil for the treatment of AD, from the establishment of the database to October 1st, 2023. The clinical efficacy rate, Mini-Mental State Examination, AD Assessment Scale for Cognitive Capacity, Skill Level on Activities of Daily Living, Montreal Cognitive Assessment, Behavioral Pathology in AD Rating Scale, and adverse events were mainly used to evaluate the outcomes. RevMan 5.4.1 software was used to evaluate the quality of the included studies and perform a meta-analysis.| | ||
| + | ^Results| A total of **12 RCTs** were included. Meta-analysis showed that acupuncture combined with donepezil seemed to be more effective than donepezil monotherapy for treatment of AD in improving the clinical efficacy rate (relative risk = 1.35; 95% confidence interval [CI]: 1.17-1.56; Z = 4.10; P < .0001), the Mini-Mental State Examination score (mean difference [MD] = 3.28; 95% CI: 1.81-4.75; Z = 4.37; P < .0001), and the Montreal Cognitive Assessment score (MD = 6.04; 95% CI: 4.76-7.32; Z = 9.23; P = .00001), while reducing the AD Assessment Scale for Cognitive Capacity score (MD = -3.57; 95% CI: -3.94 to -3.20; Z = 18.91; P < .00001), the Skill Level on Activities of Daily Living score (MD = -2.52; 95% CI: -4.05 to -0.99; Z = 3.23; P = .001), and the Behavioral Pathology in AD Rating Scale score (MD = -4.04; 95% CI: -4.58 to -3.50; Z = 14.64; P < .00001).| | ||
| + | ^Conclusions| Acupuncture combined with donepezil is an effective treatment which can improve cognitive ability and quality of life for AD patients. However, it is imperative to conduct more large-scale and high-quality RCTs in order to establish more definitive conclusions regarding this therapeutic approach in the future.| | ||
| + | |||
| + | |||
| + | |||
| + | === Guo 2024 (cognitive impairment) === | ||
| + | |||
| + | Guo R, Shen X, Ealing J, Zhou J, Lu J, Ning Y. Efficacy and safety of acupuncture for cognitive impairment in Alzheimer's disease: a systematic review and meta-analysis. Front Dement. 2024 Jul 3;3:1380221. https://doi.org/10.3389/frdem.2024.1380221 | ||
| + | ^Objective| To systematically evaluate the efficacy of acupuncture in the treatment of cognitive impairment in Alzheimer's disease (AD) by meta-analysis, in order to provide evidence-based evidence for the application of acupuncture therapy in the clinical process of AD.| | ||
| + | ^Methods| From the establishment of the database to December 31, 2022, China Biomedical Literature Database (CBM), China National Knowledge Network (CNKI), VIP database, WanFang Database, Pubmed, Embase and Cochrane Library Database were systematically searched. To collect published randomized controlled clinical trials (RCTS) of acupuncture in the treatment of cognitive impairment in AD. The subjects in the intervention group were given acupuncture alone or combined with other treatments the same as the control group; the control group received conventional Western medicine treatment. The main outcome indicators of the study were cognitive function assessment of subjects, including: Simple Mental State Examination Scale (MMSE), Assessment of daily Living Ability Scale (ADL), Alzheimer's Disease Cognitive Function Assessment Scale (ADAS-Cog), TCM syndrome score (SDSD), Montreal Cognitive Test (MoCA), Secondary outcome indicators were the occurrence of adverse reactions. Literature screening, data extraction, and quality evaluation of the included literature were performed independently by two researchers, according to bias risk assessment tools recommended in the Cochrane manual. Data were analyzed by RevMan5.3 software. Dichotomous variables were represented by risk ratio (OR) and 95% CI, and continuity variables were represented by mean difference (MD) and 95% CI. For heterogeneity analysis, when P > 0.1 and I 2 ≤ 50%, fixed effect model was applied. When P ≤ 0.1 and I 2 > 50%, the random effects model is applied.| | ||
| + | ^Results| A total of **1,172 eligible subjects were included in 18 RCTS**, including 595 in the intervention group and 577 in the control group. The results of meta-analysis are as follows: acupuncture intervention group improved MMSE [MD = 1.67, 95% CI (0.94, 2.41), P < 0.00001], ADL [MD = -1.18, 95% CI (-3.09, 0.72), P = 0.22], ADAS-Cog [MD = 3.31, 95% CI (5.84, 0.78), P = 0.01], SDSD [MD = 2.40, 95% CI (3.53, 1.26), P < 0.0001], MoCA [MD = 4.80, 95% CI (3.74, 5.86), P = 0.04] were better than the control group. No serious adverse reactions related to acupuncture were observed in the intervention group, and the incidence and severity of adverse reactions were lower than those in the control group, with statistical significance [OR = 0.17, 95% CI (0.04, 0.67), P = 0.01].| | ||
| + | ^Conclusion| Existing data show that acupuncture therapy has certain advantages in improving cognitive dysfunction and improving self-care ability of patients with Alzheimer's disease. However, due to the small number of RCTS and cases evaluating the efficacy of acupuncture, and the possibility of measurement bias and selectivity bias in included studies, it is still unable to conduct high-intensity demonstration on its effectiveness. Further large-scale, high-quality randomized, double-blind controlled trials are needed to evaluate its efficacy.| | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | === Lin 2022 === | ||
| + | |||
| + | |||
| + | Lin CJ, Yeh ML, Wu SF, Chung YC, Lee JC. Acupuncture-related treatments improve cognitive and physical functions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials. Clin Rehabil. 2022 May;36(5):609-635. https://doi.org/10.1177/02692155221079117 | ||
| + | |||
| + | ^Objective|To determine acupuncture-related treatments' effects and duration on improving cognitive function, physical function, and quality of life in patients with Alzheimer's disease.| | ||
| + | ^Data sources| Eight electronic databases were searched for eligible randomized controlled trials from database inception to January 2021, including Medline, PubMed, EBSCO, Embase, Cochrane, Airiti Library, China National Knowledge Infrastructure, and China Journal Full-text Database.| | ||
| + | ^Review methods| A systematic review and meta-analysis were conducted on acupuncture types, cognitive function, activity of daily life, muscle strength and quality of life.| | ||
| + | ^Results|**Sixty-six studies in total with 4191 participants**, the overall risk of bias was classified 60% as low and 24% as high. Acupuncture-related treatments for cognitive function and self-care ability revealed a moderate effect size, with a significant difference in noninvasive and invasive remedies (p < 0.001). Cognitive function showed significant differences in 6, 8, 12, and 24 weeks while self-care ability in the latter two weeks (p < 0.001). Meta-regression analysis showed cognitive function increased by 0.05 points (p = 0.002) and self-care ability decreased by 0.02 points (p = 0.04) after weekly treatment. There was a significant difference in muscle strength (p = 0.0003).| | ||
| + | ^Conclusion|Acupuncture-related treatments effectively improved cognitive function with the treatment lasted 6 weeks at least, but self-care ability started showing effects after 12 weeks of treatment. The improvement of muscle strength was also confirmed. Acupuncture-related treatments, particularly noninvasive ones, have few complications and high safety, perhaps providing patients and caregivers diversified choices and clinical care guidelines for reference.| | ||
| + | |||
| + | |||
| + | === Wang 2021 (Network Meta-Analysis)=== | ||
| + | |||
| + | Wang XS, Li JJ, Wang YS, Yu CC, He C, Huang ZS, Jiang T, Hao Q, Kong LH. Acupuncture and Related Therapies for the Cognitive Function of Alzheimer's Disease: A Network Meta-Analysis. Iran J Public Health. 2021 Dec;50(12):2411-2426. https://doi.org/10.18502/ijph.v50i12.7924 | ||
| + | |||
| + | ^Background| Acupuncture and acupuncture-related therapies are effective for Alzheimer's disease (AD), therefore, we aimed to compare and rank the interventions that mainly focus on acupuncture-related therapies in the treatment of patients with mild to moderate AD.| | ||
| + | ^Methods| We used network meta-analysis to evaluate the direct and indirect evidence shown in randomized controlled trials of AD. The data were analyzed using RavMan manager, Stata, and WinBUGS software after two researchers independently screened the literature, extracted the data, and assessed the risk of bias in the included studies.| | ||
| + | ^Results|We analyzed a total of 36 eligible studies, including 2712 patients, involving 14 types of acupuncture-related therapies and comprehensive therapies. For Mini-Mental State Examination (MMSE), acupuncture (ACU) combined with cognitive and memory training (Training) was more effective than ACU, ACU+Chinese herb (CH), ACU+Donepezil (DON), CH, DON, DON+Nimodipine (NIM), Music therapy (Music), NIM, Placebo, and Training (P<0.05), while ACU+CH was batter than CH (P<0.05), and ACU+DON+NIM was better than DON+NIM (P<0.05). For Alzheimer's Disease Assessment Scale-Cognitive section (ADAS-cog), ACU was more effective than DON and placebo (P<0.05). For Activities of Daily Living (ADL), ACU+DON was better than CH, DON, NIM, and Placebo (P<0.05). For the clinical effectiveness rate, ACU, ACU+CH, ACU+CH+DON, ACU+CH+DON+NIM, ACU+DON, CH, NIM were all more effective than DON+NIM (P<0.05), while ACU and ACU+CH were better than DON (P<0.05). The comprehensive ranking results show that ACU+training and ACU have the highest ranking probability.| | ||
| + | ^Conclusion|ACU+Training and ACU may be the best therapies to improve the cognitive function of patients with mild to moderate AD, while the combination of acupuncture-related therapies and other therapies has a higher overall benefit.| | ||
| === Jiao 2020 === | === Jiao 2020 === | ||
| Ligne 23: | Ligne 77: | ||
| ^Results |**Twenty-one RCTs (N = 2253)** were quantitatively analyzed. For VD, compared with Western medicine (WM), acupuncture showed better Hierarchic Dementia Scale scores (P < 0.01), and acupuncture plus WM also showed better Hierarchic Dementia Scale scores (P < 0.01). For MCI, acupuncture showed a significant improvement in Mini-Mental State Examination (P < 0.01) and picture recognition test scores compared with WM. For AD, WM resulted in better Hierarchic Dementia Scale scores than acupuncture (P < 0.01). Eight trials reported adverse events, 15 out of 2253 patients had adverse events related to acupuncture treatment, and 25 out of 2253 patients had adverse events related to WM treatment. | | ^Results |**Twenty-one RCTs (N = 2253)** were quantitatively analyzed. For VD, compared with Western medicine (WM), acupuncture showed better Hierarchic Dementia Scale scores (P < 0.01), and acupuncture plus WM also showed better Hierarchic Dementia Scale scores (P < 0.01). For MCI, acupuncture showed a significant improvement in Mini-Mental State Examination (P < 0.01) and picture recognition test scores compared with WM. For AD, WM resulted in better Hierarchic Dementia Scale scores than acupuncture (P < 0.01). Eight trials reported adverse events, 15 out of 2253 patients had adverse events related to acupuncture treatment, and 25 out of 2253 patients had adverse events related to WM treatment. | | ||
| ^ Conclusion |Acupuncture may be efficacious for improving cognitive function in patients with VD and MCI. However, the evidence is limited, and larger sample size and more rigorous RCTs should be conducted to verify the effectiveness and safety of acupuncture. | | ^ Conclusion |Acupuncture may be efficacious for improving cognitive function in patients with VD and MCI. However, the evidence is limited, and larger sample size and more rigorous RCTs should be conducted to verify the effectiveness and safety of acupuncture. | | ||
| + | |||
| + | |||
| + | === Jin 2020 === | ||
| + | |||
| + | Jin Hyeon Shin, Hye Jeong Shin, Eui Byeol Kim, Yun Young An, Tae Han Yook, Yoo Min Choi, Beom Yong Song, Jong Uk Kim. The Effectiveness of Acupuncture Treatment for Patients with Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials. J Acupunct Res. 2020;37(4):209-223. [219961]. [[https://doi.org/10.13045/jar.2020.00255|doi]] | ||
| + | ^Purpose| The purpose of this study was to evaluate the effectiveness of acupuncture treatment for the symptoms of Alzheimer’s disease (AD). | | ||
| + | ^Methods |There were 11 databases searched for randomized controlled trials using acupuncture treatment for AD. The risk-of-bias assessment tool of the Cochrane Library was used to evaluate the quality of each study. Using the Review Manager (RevMan), a meta-analysis was performed using risk ratio, mean difference, 95% confidence interval, and random effect model. | | ||
| + | ^Results |There were **32 studies** selected, all of which were conducted in China. There were 16 studies where acupuncture was used as the intervention, and 23 studies used Donepezil as the control group. Acupoint GV20 was most frequently selected during the treatment. The Mini Mental State Examination (MMSE) was the most frequently used outcome variable. A period of 12 weeks was the most common treatment duration. As a result of meta-analysis (n = 25), acupuncture improved the MMSE and activities of daily living scores. Electroacupuncture improved the Alzheimer Disease Assessment Scale-Cognitive Subscale, and scalp acupuncture improved the MMSE score for AD. | | ||
| + | ^Conclusions |Acupuncture alleviates the symptoms of AD. However, further research is necessary to provide a better level of evidence.| | ||
| Ligne 112: | Ligne 175: | ||
| ==== Special Acupuncture Techniques ==== | ==== Special Acupuncture Techniques ==== | ||
| + | |||
| + | |||
| + | === Comparison of acupuncture techniques === | ||
| + | |||
| + | == Yin 2023 (Network Meta-Analysis) == | ||
| + | |||
| + | Yin W, Chen Y, Xu A, Tang Y, Zeng Q, Wang X, Li Z. Acupuncture May Be a Potential Complementary Therapy for Alzheimer's Disease: A Network Meta-Analysis. Evid Based Complement Alternat Med. 2022 Nov 23;2022:6970751. https://doi.org/10.1155/2022/6970751 | ||
| + | |With Alzheimer's disease (AD) becoming a worldwide problem, traditional Chinese medicine (TCM), especially acupuncture, stands out as a complementary therapy because of its feature-"treatment based on syndrome differentiation". This systematic review and network meta-analysis (NMA) confirms the complement effect of acupuncture and explores the best combination of therapy for AD based on the total effect and activity of daily living scale (ADL). We searched relevant randomized controlled trials (RCTs) that applied acupuncture for treating AD. **58 studies with 4334 patients** were included in accordance with PRISMA guidelines. The results showed that for the total effect, the order of probability for the effect: acupuncture + western medicine > acupuncture + herbal medicine > acupuncture > acupuncture + western medicine + herbal medicine. For the ADL score, the order of probability for the effect: acupuncture + western medicine > acupuncture > acupuncture + western medicine + herbal medicine > acupuncture + herbal medicine. The combination of acupuncture and medicine has a better clinical effect than acupuncture only in a way. Acupuncture + western medicine has an obvious and exact improvement in the curative effect from both total effect and ADL score, but further higher quality studies, which can detail the classification of these interventions, are still needed to verify it.| | ||
| + | |||
| + | == Yin 2022 (Network Meta-Analysis) == | ||
| + | |||
| + | Yin Z, Li X, Wang L, Sun M, Zhao L, Liang F. The Comparative Efficacy of Multiple Acupuncture for Alzheimer's Disease: A Bayesian Network Meta-Analysis. Evid Based Complement Alternat Med. 2022 May 17;2022:3288948. https://doi.org/10.1155/2022/3288948 | ||
| + | ^Background| Alzheimer's disease (AD) is a progressive neurodegenerative disease. Numerous cases have illustrated that the acupuncture method could improve AD patients' cognitive function and daily living ability. However, the optimal acupuncture treatments remain controversial. Therefore, we aimed to conduct a systematic review to compare the efficacy of multiple acupuncture therapies for AD and identify the optimal acupuncture intervention for delaying AD progression.| | ||
| + | ^Methods| To select potentially concerned randomized controlled trials (RCTs), we searched four English databases, four Chinese databases, and additional sources from 1 May 2021. Two independent reviewers conducted study screening, data extraction, and methodological quality assessment. The primary outcome was global cognitive function improvement. Pairwise and Bayesian network meta-analyses were performed using STATA v15.0 and ADDIS v1.16.8. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool was used to assess the quality of evidence.| | ||
| + | ^Results| This study included **34 RCTs with 2,071 participants**. Regarding global cognitive function improvement, the pairwise meta-analysis confirmed that electronic acupuncture (EA) plus conventional medicine (CM) and manual acupuncture (MA) plus CM were statistically significantly different from CM, and EA plus CM was ranked as the best combination in the network meta-analysis. In terms of response rate, MA outperformed CM statistically significantly; warm acupuncture (WA) was ranked as the best in the network meta-analysis. Regarding activity of daily living improvement, EA plus CM, MA plus CM, and fire acupuncture plus CM, MA, and scalp acupuncture were statistically significantly different from CM, and EA plus CM was ranked as the best combination in the network meta-analysis. However, the evidences were ranked as low to critically low.| | ||
| + | ^Conclusions| Acupuncture, as a monotherapy or an adjuvant therapy, may have a beneficial effect on efficacy for AD. EA plus CM may be the optimal acupuncture therapy for AD and should be administered to AD patients. It may aid and support patient, operative, and societal decision-making. Due to the dearth of high-quality evidence, additional high-quality studies should be conducted to ensure these findings in the future. This study is registered with PROSPERO (CRD42021252305).| | ||
| + | |||
| === Combined with Traditional Chinese Medicine === | === Combined with Traditional Chinese Medicine === | ||
| + | == Wang 2023 (combined with tonifying kidney decoction) == | ||
| + | |||
| + | |||
| + | Wang XC, Chu CL, Lu K, Chen X, Jin XQ, Quan SJ. The role of tonifying kidney decoction and acupuncture in the treatment of Alzheimer's disease: A network meta-analysis. Medicine (Baltimore). 2022 Nov 18;101(46):e31243. https://doi.org/10.1097/MD.0000000000031243. | ||
| + | |||
| + | ^Importance| As one of the chronic neurological degenerative diseases with the highest incidence of amnesia and dementia, Alzheimer's disease (AD) carried out the clinical treatment based on the 2 traditional Chinese medicine (TCM) of Chinese herbal compound and acupuncture (AP). With the vigorous development of TCM, doctors are facing the problem of choosing TCM or western medicine in clinical work. Hence there is an urge to make pairwise comparisons among these interventions to provide evidence for clinical practice.| | ||
| + | ^Objective| The used efficacy of the 2 TCM methods and combined with donepeziline were compared to compile the best treatment through network meta-analysis.| | ||
| + | ^Methods|Patients diagnosed with AD were included in the randomized clinical trial, who were treated with tonifying kidney decoction (TKD) or AP combined with donepezil hydrochloride (DH) as an intervention measure, while the control group was treated with DH. The total effective rate was the primary outcome, and mini-mental state examination (MMSE) score and activities of daily living (ADCS-ADL) scores were the secondary indicators.| | ||
| + | ^Results|Eventually **30 studies reporting 2236 patients** underwent TKD or AP combined with DH were enrolled. In terms of total efficiency, compared with TKD and DH, TKD + DH was significantly preferable. In addition, TKD were classified into 2 categories, namely tonifying kidney with reducing phlegm formulas (TKRP) and tonifying kidney with filling lean marrow (TKFLM). Regarding to MMSE score of TKD, of the 3 interventions, only TKRP + DH (standard mean difference [SMD] = 4.84, 95% confidence interval [CI]: 0.86-8.82) and TKFLM + DH (SMD = 3.93, 95% CI: 1.06-6.80) had significant efficacy over TKFLM (SMD = 4.25, 95%CI: -2.58 to 11.08). Although no difference between TKRP and other groups, its effectiveness was higher than TKFLM + DH and TKFLM (surface under the cumulative ranking curve (SUCRA) = 61.5%). For the ADL score, compared with TKFLM + DH and DH, TKRP + DH had more effective (SUCRA = 70.2%). Regarding to the total effective rates, AP + DH was more statistically better than AP, and AP was statistically better than DH.| | ||
| + | ^Conclusion|TKD or AP in combination with DH are significantly superior in treating AD.| | ||
| == Jiao 2020 == | == Jiao 2020 == | ||
| Ligne 136: | Ligne 226: | ||
| ^Conclusions|From the current research results, acupuncture plus herbal medicine may have advantages over western drugs for treating AD. Nevertheless, well-designed RCTs with a larger sample size are required in the future. | | ^Conclusions|From the current research results, acupuncture plus herbal medicine may have advantages over western drugs for treating AD. Nevertheless, well-designed RCTs with a larger sample size are required in the future. | | ||
| - | === Zou 2016 ☆ === | + | == Zou 2016 ☆ == |
| Zou Jingfeng, Guo Peiyan, Xie Ke, Dong Xushuai, Zhao Fei. [Meta-analysis of the effectiveness of acupuncture treatment combined with traditional chinese medicine treatment of Alzheimer disease]. China Journal of Chinese Medicine. 2016;1:138-143. [186905].<wrap lo>目的: 比较针刺联合中药与单用中药治疗阿尔茨海默病的疗效差异. 方法: 通过检索PubMed、Embase、CNKI等中外论文数据库, 筛选出针药对照单用中药治疗阿尔茨海默病的随机临床对照试验. 对符合标准的文献评价质量, 并应用RevMan Manager 5. 2软件进行Meta分析. 结果: 纳入共包括335例患者的6篇文献. Meta分析结果显示, 针药结合、单用中药治疗阿尔茨海默病后的有效率分别为76. 96％和65. 28％, 合并效应量的比值比OR=1. 89, (95％ CI=1. 11, 3. 21), P=0. 02 ＜0. 05, 提示差异有统计学意义;针药与单用中药治疗阿尔茨海默病后的MMSE、ADL量表评分的分析结果分别为MD=1. 55, (95％CI=0. 98, 2. 12), P＜0. 000 01、WMD=0. 36, (95％ CI=0. 14, 0. 59), P=0. 002, 以上结果P均＜0. 05, 提示治疗前后量表评分改变上针药与单用中药的疗效比较, 差异有统计学意义. 结论: 针药结合比单用中药治疗阿尔茨海默病更具优势, 但仍需更多大样本高质量的随机临床对照试验进一步验证.</wrap> | Zou Jingfeng, Guo Peiyan, Xie Ke, Dong Xushuai, Zhao Fei. [Meta-analysis of the effectiveness of acupuncture treatment combined with traditional chinese medicine treatment of Alzheimer disease]. China Journal of Chinese Medicine. 2016;1:138-143. [186905].<wrap lo>目的: 比较针刺联合中药与单用中药治疗阿尔茨海默病的疗效差异. 方法: 通过检索PubMed、Embase、CNKI等中外论文数据库, 筛选出针药对照单用中药治疗阿尔茨海默病的随机临床对照试验. 对符合标准的文献评价质量, 并应用RevMan Manager 5. 2软件进行Meta分析. 结果: 纳入共包括335例患者的6篇文献. Meta分析结果显示, 针药结合、单用中药治疗阿尔茨海默病后的有效率分别为76. 96％和65. 28％, 合并效应量的比值比OR=1. 89, (95％ CI=1. 11, 3. 21), P=0. 02 ＜0. 05, 提示差异有统计学意义;针药与单用中药治疗阿尔茨海默病后的MMSE、ADL量表评分的分析结果分别为MD=1. 55, (95％CI=0. 98, 2. 12), P＜0. 000 01、WMD=0. 36, (95％ CI=0. 14, 0. 59), P=0. 002, 以上结果P均＜0. 05, 提示治疗前后量表评分改变上针药与单用中药的疗效比较, 差异有统计学意义. 结论: 针药结合比单用中药治疗阿尔茨海默病更具优势, 但仍需更多大样本高质量的随机临床对照试验进一步验证.</wrap> | ||
| Ligne 147: | Ligne 237: | ||
| + | === Warm needle === | ||
| + | |||
| + | == Chen 2022 == | ||
| + | |||
| + | |||
| + | Chen X, Liu F, Lin N, Lin Q, Lyu Z, Xiu H, Nie P. Warming needle moxibustion for Alzheimer's disease: A systematic review of randomized controlled trials. Geriatr Nurs. 2022 Jan-Feb;43:219-226. https://doi.org/10.1016/j.gerinurse.2021 | ||
| + | |||
| + | ^Objective| To systematically research the impact of warming needle moxibustion (WNM) for Alzheimer's Disease (AD).| | ||
| + | ^Methods|Four Chinese databases and six English databases were systematically searched. Randomized controlled trials (RCTs) involving the use of WNM to intervene in AD patients were included. Data were extracted from the included studies and methodological quality was evaluated according to the Cochrane Handbook for Systematic Reviews of Intervention 5.1.0. Meta-analysis was performed using RevMan 5.4 software.| | ||
| + | ^Results|**8 RCTs comprising 524 patients** were included. Most studies had no significant bias. The study showed that WNM was more effective in the treatment of AD than acupuncture or pharmacotherapy. The findings were as follows: MMSE (MD = 1.01, 95%CI: 0.13, 1.90, P = 0.03) and CDR (MD = -0.73, 95%CI: -0.84, -0.61, P < 0.00001) for global cognitive function, ADL (MD = -1.84, 95%CI: -2.47, -1.22, P < 0.00001) for activities of daily living, Syndrome Differentiation Scale of Dementia (SDSD) (MD = -2.67, 95%CI: -3.62, -1.72, P < 0.00001), and the total effective rate of patients (OR = 3.20, 95%CI: 1.90 to 5.38, P < 0.0001). The differences in all indicators were statistically significant.| | ||
| + | ^Conclusion| WNM might have a significant effect on improving cognitive function and daily living ability, reducing the symptoms of AD, and increase the total effective rate. WNM is an effective non-pharmacological therapy for patients with AD.| | ||
| + | |||
| + | ===== Overviews of systematic reviews ===== | ||
| + | |||
| + | ==== Ke 2024 ==== | ||
| + | |||
| + | |||
| + | Ke C, Shan S, Yu J, Wei X, Pan J, Zhang W. Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis. J Alzheimers Dis. 2024 Dec;102(4):924-942. https://doi.org/10.1177/13872877241295400 | ||
| + | ^Backgound| Acupuncture is an effective complementary treatment for Alzheimer's disease (AD). This review aims to summarize the available evidence provided by randomized controlled trials (RCTs) and systematic reviews (SRs) or meta-analyses (MAs) on the effect of acupuncture on AD. | | ||
| + | ^Objective| To systematically summarize and combine clinical research evidence on AD distribution. | | ||
| + | ^Methods| We conducted a comprehensive search of various databases, including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan Fang Data, Chinese BioMedical Literature Database (CBM) and Chonqing VIP (CQVIP), from their inception to September 2023. Relevant literature about acupuncture for AD was included, and the characteristics of the evidence map were presented through charts and textual analyses. | | ||
| + | ^Results| In total, **117 RCTs and 17 SRs or MAs** were included. The results were divided into three categories: basic characteristics of the included literature, clinical characteristics and quality assessment of the included RCTs, and clinical characteristics and quality assessment of the included SRs and MAs. | | ||
| + | ^Conclusions| Acupuncture as a therapeutic measure for AD has some advantages in improving cognition and quality of life; thus, it is imperative to conduct multi-center, large-scale RCTs to enhance the evidence supporting the use of acupuncture in AD. This is the first evidence map exploring acupuncture treatment for AD, providing insights into the current clinical research landscape on acupuncture treatment for AD. Furthermore, the findings of this study highlight research gaps in this field and serve as a valuable reference for guiding the planning and selection of topics for future research.| | ||
